Werewolf Therapeutics Inc...

NASDAQ: HOWL · Real-Time Price · USD
1.35
0.03 (2.27%)
At close: Aug 15, 2025, 2:21 PM

Werewolf Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.91 -3.68 -1.1 -6.54
PEG Ratio
-0.02 0.08 0.01 -0.01
PS Ratio
34.02 6.90 3.61 n/a
PB Ratio
0.87 1.24 0.48 2.13
P/FCF Ratio
-1.14 -4.12 -1.34 -7.5
P/OCF Ratio
-1.14 -4.22 -1.46 -7.59
OCF/S Ratio
-29.81 -1.64 -2.48 n/a
Debt / Equity Ratio
0.51 0.47 0.12 0.10
Quick Ratio
7.45 7.14 5.84 13.56
Current Ratio
7.45 7.14 5.84 13.56
Asset Turnover
0.01 0.11 0.10 n/a
Interest Coverage
-15.81 -12.9 n/a n/a
Return on Equity
-0.96 -0.34 -0.44 -0.33
Return on Assets
-0.56 -0.21 -0.34 -0.28
Return on Invested Capital
-0.64 -0.25 -0.4 -0.29
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.04 0.91 0.85 n/a
Net Profit Margin
-37.41 -1.87 -3.28 n/a
Pretax Profit Margin
-37.41 -1.87 -3.28 n/a
Operating Profit Margin
-39.04 -2.03 -3.42 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-33.98 -1.63 -3.13 n/a